Susquehanna International Group, LLP Harmony Biosciences Holdings, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 62,545 shares of HRMY stock, worth $2.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,545
Previous 18,329
241.24%
Holding current value
$2.01 Million
Previous $630,000
229.37%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HRMY
# of Institutions
278Shares Held
44.8MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$212 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$187 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$151 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$50.6 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$41.3 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.9B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...